StoryRegulatory
Versius receives CE Mark approval in Europe
CMR Surgical secured CE Mark approval for Versius, clearing the path for deployment in European hospitals and expanding beyond the UK.
Source: Press (link not recorded)
More on CMR Surgical
- Versius surpasses 45,000 completed surgical procedures globallyMar 2026
- Versius gains CE Mark approval for paediatric surgeryJan 2026
- Versius Plus receives FDA 510(k) clearance for cholecystectomyDec 2025
- CMR Surgical raises $200M in growth funding at $3B valuationApr 2025
- Versius receives FDA De Novo marketing authorisation in the United StatesOct 2024
- Versius surpasses 20,000 completed surgical proceduresMar 2024